These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 2686349)
1. Immunohistochemical and immunoblot analyses of ras-p21 expression in lung carcinomas. Koshiishi Y; Noguchi M; Nakajima T; Hirohashi S; Shimosato Y; Hayata Y Acta Pathol Jpn; 1989 Oct; 39(10):643-7. PubMed ID: 2686349 [TBL] [Abstract][Full Text] [Related]
2. Comparative immunohistochemical reactivity of monoclonal and polyclonal antibodies to H-ras p21 in normal and neoplastic tissues of rodents and humans. Ward JM; Perantoni AO; Santos E Oncogene; 1989 Feb; 4(2):203-13. PubMed ID: 2648257 [TBL] [Abstract][Full Text] [Related]
3. Enhanced expression of c-Ha-ras p21 in human stomach adenocarcinomas defined by immunoassays using monoclonal antibodies and in situ hybridization. Ohuchi N; Hand PH; Merlo G; Fujita J; Mariani-Costantini R; Thor A; Nose M; Callahan R; Schlom J Cancer Res; 1987 Mar; 47(5):1413-20. PubMed ID: 2434216 [TBL] [Abstract][Full Text] [Related]
4. Clinical and histopathologic evaluation of the expression of Ha-ras and fes oncogene products in lung cancer. Nishio H; Nakamura S; Horai T; Ikegami H; Matsuda M Cancer; 1992 Mar; 69(5):1130-6. PubMed ID: 1310887 [TBL] [Abstract][Full Text] [Related]
5. ras p21 oncoprotein expression in human colonic neoplasia--an immunohistochemical study with monoclonal antibody RAP-5. Lanza G Histopathology; 1988 Jun; 12(6):595-609. PubMed ID: 3047043 [TBL] [Abstract][Full Text] [Related]
6. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis]. Irie K; Ishida H; Furukawa T; Koyanagi K; Miyamoto Y Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of normal and mutated ras oncogene p21 expression in human pulmonary and pleural neoplasms. Radosevich JA; Gould VE; Ma Y; Lee I; Thor A; Carney WP; Warren WH; Schlom J; Rosen ST Virchows Arch B Cell Pathol Incl Mol Pathol; 1989; 56(6):377-83. PubMed ID: 2567085 [TBL] [Abstract][Full Text] [Related]
8. Histologic demonstration of antigens reactive with anti-p21 ras monoclonal antibody (RAP-5) in human stomach cancers. Noguchi M; Hirohashi S; Shimosato Y; Thor A; Schlom J; Tsunokawa Y; Terada M; Sugimura T J Natl Cancer Inst; 1986 Aug; 77(2):379-85. PubMed ID: 3525957 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of human lung cancers with anti-ras p21 monoclonal antibodies. Dosaka H; Harada M; Kuzumaki N; Kobayashi H; Isobe H; Miyamoto H; Kawakami Y Int J Biol Markers; 1987; 2(2):75-82. PubMed ID: 3330557 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of nuclear DNA content and expression of the ras oncogene product in lung cancer. Miyamoto H; Harada M; Isobe H; Akita HD; Haneda H; Yamaguchi E; Kuzumaki N; Kawakami Y Cancer Res; 1991 Dec; 51(23 Pt 1):6346-50. PubMed ID: 1657384 [TBL] [Abstract][Full Text] [Related]
11. [A study on P21(ras) in human lung cancer and body fluid of cancer patients]. Lin X; Shu X; Sun Z; Zhao J; Sun Z Hua Xi Yi Ke Da Xue Xue Bao; 1993 Sep; 24(3):233-6. PubMed ID: 8288186 [TBL] [Abstract][Full Text] [Related]
12. Expression of ras oncogene p21 during human fetal development as determined by monoclonal antibodies RAP-5, Y13-259, and DWP. Radosevich JA; Combs SG; Ma Y; Lee I; Gould VE; Thor A; Schlom J; Carney WP; Rosen ST Virchows Arch B Cell Pathol Incl Mol Pathol; 1989; 56(5):337-44. PubMed ID: 2565631 [TBL] [Abstract][Full Text] [Related]
13. Trisomy 12 correlates with elevated expression of p21 ras in a human adenosquamous carcinoma of the lung. Liang JC; Kurzrock R; Gutterman JU; Gallick GE Cancer Genet Cytogenet; 1986 Oct; 23(2):183-8. PubMed ID: 3530433 [TBL] [Abstract][Full Text] [Related]
14. Expression of ras p21 protein by thymoma. Mukai K; Sato Y; Hirohashi S; Shimosato Y Virchows Arch B Cell Pathol Incl Mol Pathol; 1990; 59(1):11-6. PubMed ID: 1974093 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical detection of ras 21 in oral squamous cell carcinomas. Satoh M; Hatakeyama S; Sashima M; Suzuki A Oral Surg Oral Med Oral Pathol; 1992 Oct; 74(4):469-72. PubMed ID: 1408023 [TBL] [Abstract][Full Text] [Related]
16. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung. Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992 [TBL] [Abstract][Full Text] [Related]
17. [Expression of ras oncogene product P21 in thyroid tumors: an immunohistochemical study]. Gui K Zhonghua Yi Xue Za Zhi; 1990 Mar; 70(3):140-2, 12. PubMed ID: 2163739 [TBL] [Abstract][Full Text] [Related]
18. Expression of ras oncogene p21 protein in early gastric carcinoma and adjacent gastric epithelia. Czerniak B; Herz F; Gorczyca W; Koss LG Cancer; 1989 Oct; 64(7):1467-73. PubMed ID: 2550123 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical demonstration of ras p21 oncogene product in normal, benign, and malignant human thyroid tissues. Mizukami Y; Nonomura A; Hashimoto T; Terahata S; Matsubara F; Michigishi T; Noguchi M Cancer; 1988 Mar; 61(5):873-80. PubMed ID: 3276392 [TBL] [Abstract][Full Text] [Related]
20. On the relevance of a testing algorithm for the detection of ROS1-rearranged lung adenocarcinomas. Mescam-Mancini L; Lantuéjoul S; Moro-Sibilot D; Rouquette I; Souquet PJ; Audigier-Valette C; Sabourin JC; Decroisette C; Sakhri L; Brambilla E; McLeer-Florin A Lung Cancer; 2014 Feb; 83(2):168-73. PubMed ID: 24380695 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]